Health Minister Dr Aaron Motsoaledi has revealed that medicines frequently affected by stock disruptions include antibiotics, tuberculosis medicines, oncology products, insulin, and selected ...

What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...

The in-house Iris chip starts manufacturing in September with “no major issues” after six weeks of testing, directly ...

The company expects shipments to resume by November, and has halves FY27 supply estimate, while saying patient safety and ...

Byrna Technologies (NASDAQ:BYRN) reported second-quarter financial results on Thursday. The transcript from the company's ...

When launching a drug as big as semaglutide, even as a generic, the market expectations are immense, and any fumble on the ...

Dr. Reddy’s Laboratories Ltd. will delay the commercial production of its generic Ozempic drug after it found an unspecified ...

A “Godzilla” El Niño could disrupt pharma supply chains, pushing life sciences firms toward AI-driven weather forecasting, ...

Evonik Industries AG (Essen, Germany) is making a significant investment to strengthen manufacturing capabilities at its ...

China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...

Section 232 introduces a staged tariff regime: 100% default for patented drugs/APIs/KSMs, reduced 20% with approved onshoring plans, and temporary 0% if paired with MFN pricing until 2029. Deadlines ...